369 related articles for article (PubMed ID: 17267154)
1. [The latest data on posaconazole].
Paugam A
Med Mal Infect; 2007 Feb; 37(2):71-6. PubMed ID: 17267154
[TBL] [Abstract][Full Text] [Related]
2. Posaconazole: an extended-spectrum triazole antifungal agent.
Schiller DS; Fung HB
Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
[TBL] [Abstract][Full Text] [Related]
3. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.
Nagappan V; Deresinski S
Clin Infect Dis; 2007 Dec; 45(12):1610-7. PubMed ID: 18190324
[TBL] [Abstract][Full Text] [Related]
4. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
Clark NM; Grim SA; Lynch JP
Semin Respir Crit Care Med; 2015 Oct; 36(5):767-85. PubMed ID: 26398542
[TBL] [Abstract][Full Text] [Related]
5. Posaconazole: clinical pharmacology and potential for management of fungal infections.
Groll AH; Walsh TJ
Expert Rev Anti Infect Ther; 2005 Aug; 3(4):467-87. PubMed ID: 16107193
[TBL] [Abstract][Full Text] [Related]
6. Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.
Smith WJ; Drew RH; Perfect JR
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):165-81. PubMed ID: 19254165
[TBL] [Abstract][Full Text] [Related]
7. Posaconazole: a next-generation triazole antifungal.
Farowski F; Vehreschild JJ; Cornely OA
Future Microbiol; 2007 Jun; 2(3):231-43. PubMed ID: 17661696
[TBL] [Abstract][Full Text] [Related]
8. Posaconazole: an oral triazole with an extended spectrum of activity.
Rachwalski EJ; Wieczorkiewicz JT; Scheetz MH
Ann Pharmacother; 2008 Oct; 42(10):1429-38. PubMed ID: 18713852
[TBL] [Abstract][Full Text] [Related]
9. Use of posaconazole in the treatment of invasive fungal infections.
Mehta AK; Langston AA
Expert Rev Hematol; 2009 Dec; 2(6):619-30. PubMed ID: 21082953
[TBL] [Abstract][Full Text] [Related]
10. Posaconazole.
Keating GM
Drugs; 2005; 65(11):1553-67; discussion 1568-9. PubMed ID: 16033292
[TBL] [Abstract][Full Text] [Related]
11. Posaconazole: a broad-spectrum triazole antifungal.
Torres HA; Hachem RY; Chemaly RF; Kontoyiannis DP; Raad II
Lancet Infect Dis; 2005 Dec; 5(12):775-85. PubMed ID: 16310149
[TBL] [Abstract][Full Text] [Related]
12. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
[TBL] [Abstract][Full Text] [Related]
13. Posaconazole: a new antifungal weapon.
Aperis G; Alivanis P
Rev Recent Clin Trials; 2011 Sep; 6(3):204-19. PubMed ID: 21682687
[TBL] [Abstract][Full Text] [Related]
14. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
15. Posaconazole : a review of its use in the prophylaxis of invasive fungal infections.
Frampton JE; Scott LJ
Drugs; 2008; 68(7):993-1016. PubMed ID: 18457464
[TBL] [Abstract][Full Text] [Related]
16. Posaconazole: a new broad-spectrum antifungal agent.
Kwon DS; Mylonakis E
Expert Opin Pharmacother; 2007 Jun; 8(8):1167-78. PubMed ID: 17516880
[TBL] [Abstract][Full Text] [Related]
17. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR
Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103
[TBL] [Abstract][Full Text] [Related]
18. Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
Groll AH; Walsh TJ
Mycoses; 2006; 49 Suppl 1():7-16. PubMed ID: 16961576
[TBL] [Abstract][Full Text] [Related]
19. Posaconazole: a pharmacoeconomic review of its use in the prophylaxis of invasive fungal disease in immunocompromised hosts.
Lyseng-Williamson KA
Pharmacoeconomics; 2011 Mar; 29(3):251-68. PubMed ID: 21309616
[TBL] [Abstract][Full Text] [Related]
20. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.
Mullane K; Toor AA; Kalnicky C; Rodriguez T; Klein J; Stiff P
Transpl Infect Dis; 2007 Jun; 9(2):89-96. PubMed ID: 17461992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
